H1N1 (swine flu) & the R&D-based Pharmaceutical Industry

Statement 20 Sep 2023

Statement at the High-Level Meeting on Pandemic Prevention, Preparedness and Response

On 20 September 2023, IFPMA submitted a statement at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response in New York.

Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity

Ahead of discussions at the United Nations General Assembly (UNGA78), the trade association representing the innovative pharmaceutical industry, the IFPMA, has warned that current pandemic preparedness plans should not undermine what worked well in response to COVID-19 and must support both “innovation and equity.”

Fourth meeting of the Working Group on Amendments to the International Health Regulations

On 24 July, IFPMA made a statement at the fourth meeting of the Working Group on Amendments to the International Health Regulations (2005) in Geneva.